NuPathe to Present at the 11th Annual Needham Healthcare Conference

NuPathe to Present at the 11th Annual Needham Healthcare Conference

ID: 131170

(firmenpresse) - CONSHOHOCKEN, PA -- (Marketwire) -- 04/02/12 -- NuPathe Inc. (NASDAQ: PATH), a biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, today announced that , chief executive officer, will present a company overview at the 11th Annual Needham Healthcare Conference on Tuesday, April 3, 2012, at 8:40 a.m. EDT. The conference is being held at the New York Palace Hotel in New York, NY.

A live audio webcast of the presentation will be available via the "Investor Relations" page of the NuPathe website, . Please log on through NuPathe's website approximately 10 minutes prior to the scheduled start time. A replay of the webcast will also be archived on NuPathe's website for 90 days following the presentation.

Inc. is a biopharmaceutical company focused on innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders. NuPathe's lead product candidate, , is an active, single-use, transdermal sumatriptan patch being developed for the treatment of migraine. In addition to NP101, NuPathe has two proprietary product candidates in preclinical development: for the continuous symptomatic treatment of Parkinson's disease and for the long-term treatment of schizophrenia and bipolar disorder. NuPathe is actively seeking partnerships to maximize the commercial potential for our pipeline products in the U.S. and territories throughout the world.

For more information about NuPathe, please visit our website and our blog at . You can also follow us on StockTwits (), Twitter (), SlideShare () and LinkedIn ().



John Woolford
Westwicke Partners, LLC
(443) 213-0506


Keith A. Goldan
Vice President & Chief Financial Officer
NuPathe Inc.
(484) 567-0130



Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Pivotal Therapeutics Inc. Grants Incentive Stock Options Pivotal Therapeutics Inc. Begins Trading on the OTCQX
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 02.04.2012 - 18:30 Uhr
Sprache: Deutsch
News-ID 131170
Anzahl Zeichen: 0

contact information:
Town:

CONSHOHOCKEN, PA



Kategorie:

Drugs



Diese Pressemitteilung wurde bisher 250 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"NuPathe to Present at the 11th Annual Needham Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von

NuPathe Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von NuPathe Inc.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z